Literature DB >> 30505382

"Clinical Impact of the Cryoballoon Temperature and Occlusion Status on the Success of Pulmonary Vein Isolation".

Takuro Nishimura1, Kaoru Okishige1, Yasuteru Yamauchi1, Hideshi Aoyagi1, Naruhiko Ito1, Yusuke Tsuchiya1, Takatoshi Shigeta1, Rena Nakamura1, Mitsutoshi Asano1, Mitsumi Yamashita1, Tomofumi Nakamura1, Hidetoshi Suzuki1, Tsukasa Shimura1, Manabu Kurabayashi1, Takehiko Keida2, Tetsuo Sasano1, Kenzo Hirao3.   

Abstract

BACKGROUND: Complete occlusion of the pulmonary veins (PVs) with the cryoballoon (CB) is considered to be the crucial factor for a successful PV isolation (PVI). We investigated whether a complete occlusion was indispensable for a successful CB based PVI of every PV. METHODS AND
RESULTS: Atrial fibrillation patients (n=123, 97; paroxysmal) undergoing a de novo PVI were enrolled. A total of 477 PVs were analyzed. The occlusion grade (OG) was scored as follows: OG3 (complete occlusion), OG2 (incomplete occlusion with slight leakage), OG1 (poor occlusion with massive leakage). There was no significant difference in the CB temperature (CBT) at all measured time points (from 30 to 120sec after freezing) and nadir CBT between OG2 and OG3 in all PVs except for the right inferior PV (RIPV). The RIPV isolation success rate was significantly lower for the OG2 status than OG3 (97.5 vs. 57.6%; p<0.0001). In contrast, there was not significant difference in the isolation success rate of the other three PVs between OG2 and OG3. In particular, the success rate of the right superior PV (RSPV) isolation was >95% for both OG2 and OG3. Phrenic nerve paralysis (PNP) was provoked during the RSPV isolation in two patients in whom the RSPVs were frozen during OG3.
CONCLUSION: An OG3 may not always be required for a successful PVI of all PVs except the RIPV. OG2 could have comparable effects as OG3 in terms of a successful RSPV isolation. Not aiming for OG3 for the RSPV may reduce the risk of PNP.

Entities:  

Keywords:  Cryoballoon; Occlusion Grade; Phrenic Nerve Paralysis ; Pulmonary Vein Isolation

Year:  2018        PMID: 30505382      PMCID: PMC6244301          DOI: 10.4022/jafib.2065

Source DB:  PubMed          Journal:  J Atr Fibrillation        ISSN: 1941-6911


  21 in total

1.  Pulmonary vein ostium shape and orientation as possible predictors of occlusion in patients with drug-refractory paroxysmal atrial fibrillation undergoing cryoballoon ablation.

Authors:  Antonio Sorgente; Gian Battista Chierchia; Carlo de Asmundis; Andrea Sarkozy; Mehdi Namdar; Lucio Capulzini; Yoshinao Yazaki; Stephan-Andreas Müller-Burri; Fatih Bayrak; Pedro Brugada
Journal:  Europace       Date:  2010-10-25       Impact factor: 5.214

2.  Impact of transseptal puncture site on acute and mid-term outcomes during cryoballoon ablation: a comparison between anterior, medial and posterior transatrial access.

Authors:  Gian-Battista Chierchia; Ruben Casado-Arroyo; Carlo de Asmundis; Moises Rodriguez-Manero; Andrea Sarkozy; Giulio Conte; Juan Sieira; Moises Levinstein; Giannis Baltogiannis; Giacomo di Giovanni; Ingrid Overeinder; Salvatore Ocello; Eligio Rosas; Francesco Isola; Pedro Brugada
Journal:  Int J Cardiol       Date:  2013-08-05       Impact factor: 4.164

3.  Safety and efficacy of a second-generation cryoballoon in the ablation of paroxysmal atrial fibrillation.

Authors:  Raphaël P Martins; David Hamon; Olivier Césari; Albin Behaghel; Nathalie Behar; Jean-Marc Sellal; Jean-Claude Daubert; Philippe Mabo; Dominique Pavin
Journal:  Heart Rhythm       Date:  2014-01-01       Impact factor: 6.343

4.  The permanency of pulmonary vein isolation using a balloon cryoablation catheter.

Authors:  Humera Ahmed; Petr Neuzil; Jan Skoda; Andre D'Avila; David M Donaldson; Margaret C Laragy; Vivek Y Reddy
Journal:  J Cardiovasc Electrophysiol       Date:  2010-02-01

5.  Durability of Pulmonary Vein Isolation with Cryoballoon Ablation: Results from the Sustained PV Isolation with Arctic Front Advance (SUPIR) Study.

Authors:  Vivek Y Reddy; Lucie Sediva; Jan Petru; Jan Skoda; Milan Chovanec; Zita Chitovova; Paola Di Stefano; Ethel Rubin; Srinivas Dukkipati; Petr Neuzil
Journal:  J Cardiovasc Electrophysiol       Date:  2015-04-15

6.  Direct pressure monitoring accurately predicts pulmonary vein occlusion during cryoballoon ablation.

Authors:  Ioanna Kosmidou; Shannnon Wooden; Brian Jones; Thomas Deering; Andrew Wickliffe; Dan Dan
Journal:  J Vis Exp       Date:  2013-02-26       Impact factor: 1.355

7.  Phrenic nerve paralysis during cryoballoon ablation for atrial fibrillation: a comparison between the first- and second-generation balloon.

Authors:  Ruben Casado-Arroyo; Gian-Battista Chierchia; Giulio Conte; Moisés Levinstein; Juan Sieira; Moises Rodriguez-Mañero; Giacomo di Giovanni; Yannis Baltogiannis; Kristel Wauters; Carlo de Asmundis; Andrea Sarkozy; Pedro Brugada
Journal:  Heart Rhythm       Date:  2013-07-24       Impact factor: 6.343

8.  Circumferential pulmonary vein isolation with the cryoballoon technique results from a prospective 3-center study.

Authors:  Thomas Neumann; Jürgen Vogt; Burghard Schumacher; Anja Dorszewski; Malte Kuniss; Hans Neuser; Klaus Kurzidim; Alexander Berkowitsch; Marcus Koller; Johannes Heintze; Ursula Scholz; Ulrike Wetzel; Michael A E Schneider; Dieter Horstkotte; Christian W Hamm; Heinz-Friedrich Pitschner
Journal:  J Am Coll Cardiol       Date:  2008-07-22       Impact factor: 24.094

9.  Pressure-guided cryoballoon isolation of the pulmonary veins for the treatment of paroxysmal atrial fibrillation.

Authors:  Claudia Herrera Siklódy; Jan Minners; Martin Allgeier; Hans-Jürgen Allgeier; Nikolaus Jander; Cornelius Keyl; Reinhold Weber; Jochen Schiebeling-Römer; Dietrich Kalusche; Thomas Arentz
Journal:  J Cardiovasc Electrophysiol       Date:  2009-09-28

10.  The 'single big cryoballoon' technique for acute pulmonary vein isolation in patients with paroxysmal atrial fibrillation: a prospective observational single centre study.

Authors:  Kyoung-Ryul Julian Chun; Boris Schmidt; Andreas Metzner; Roland Tilz; Thomas Zerm; Ilka Köster; Alexander Fürnkranz; Buelent Koektuerk; Melanie Konstantinidou; Matthias Antz; Feifan Ouyang; Karl Heinz Kuck
Journal:  Eur Heart J       Date:  2008-12-24       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.